Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: Results of a prospective phase I trial

References

• Stauffer PR. Evolving technology for thermal therapy of cancer. Int J Hyperthermia 2005; 21: 731–744
   PubMed Web of Science ®Google Scholar
• Hildebrandt B, Wust P, Ahlers O, Dieing A, Sreenivasa G, Kerner T, Felix R, Riess H. The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol 2002; 43: 33–56
   PubMed Web of Science ®Google Scholar
• Jordan A, Maier-Hauff K, Wust P, Johannsen M. Nanoparticles for thermotherapy. Nanomaterials for cancer therapy, CSSR Kumar. Wiley-VCH, Weinheim 2006; 242–258
   Google Scholar
• Jordan A, Wust P, Fähling H, John W, Hinz A, Felix R. Inductive heating of ferrimagnetic particles and magnetic fluids: Physical evaluation of their potential for hyperthermia. Int J Hyperthermia 1993; 9(1)51–68
   PubMed Web of Science ®Google Scholar
• Johannsen M, Jordan A, Scholz R, Lein M, Koch M, Deger S, Roigas J, Jung K, Loening SA. Evaluation of magnetic fluid hyperthermia in a standard rat model of prostate cancer. J Endourol 2004; 18: 495–500
   PubMed Web of Science ®Google Scholar
• Johannsen M, Thiesen B, Jordan A, Taymoorian K, Gneveckow U, Waldöfner N, Scholz R, Koch M, Lein M, Jung K, et al. Magnetic fluid hyperthermia (MFH) reduces prostate cancer growth in the orthotopic Dunning R3327 rat model. Prostate 2005; 64(1)283–92
   PubMed Web of Science ®Google Scholar
• Johannsen M, Thiesen B, Gneveckow U, Taymoorian K, Waldöfner N, Scholz R, Deger S, Jung K, Loening SA, Jordan A. Thermotherapy using magnetic nanoparticles combined with external radiation in an orthotopic rat model of prostate cancer. Prostate 2006; 66(1)97–104
   PubMed Web of Science ®Google Scholar
• Touma NJ, Izawa JI, Chin JL. Current status of local salvage therapies following radiation failure for prostate cancer. J Urol 2005; 173: 373–379
   PubMed Web of Science ®Google Scholar
• Johannsen M, Gneveckow U, Thiesen B, Taymoorian K, Cho CH, Waldöfner N, Scholz R, Jordan A, Loening SA, Wust P. Thermotherapy of prostate cancer using magnetic nanoparticles: Feasibility, imaging and three-dimensional temperature distribution. Eur Urol Nov 17, 2006, (Epub ahead of print)
   Google Scholar
• Johannsen M, Gneveckow U, Eckelt L, Feussner A, Waldöfner N, Scholz R, Deger S, Wust P, Loening SA, Jordan A. Clinical hyperthermia of prostate cancer using magnetic nanoparticles: Presentation of a new interstitial technique. Int J Hyperthermia 2005; 21: 637–647
   PubMed Web of Science ®Google Scholar
• Aaronson NK, Ahmedzai S, Bergmann B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC. The European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365–376
   PubMed Web of Science ®Google Scholar
• Borghede G, Sullivan M. Measurement of quality of life in localized prostatic cancer patients treated with radiotherapy. Development of a prostate cancer-specific module supplementing the EORTC QLQ-C30. Qual Life Res 1996; 5: 212–222
   PubMed Web of Science ®Google Scholar
• Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998; 16: 139–144
   PubMed Web of Science ®Google Scholar
• Ryu S, Brown SL, Khil MS, Kim SH, Kim JH. Preferential radiosensitization of human prostatic carcinoma cells by mild hyperthermia. Int J Radiat Oncol Biol Phys 1996; 34: 133–138
   PubMed Web of Science ®Google Scholar
• Van Vulpen M, De Leeuw AA, Raaymakers BW, Van Moorselaar RJ, Hofman P, Lagendijk JJ, Battermann JJ. Radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate cancer: Preliminary results. BJU Int 2004; 93: 36–41
   PubMed Web of Science ®Google Scholar
• Anscher MS, Samulski TV, Dodge R, Prosnitz LR, Dewhirst MW. Combined external beam irradiation and external regional hyperthermia for locally advanced adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys 1997; 37: 1059–1065
   PubMed Web of Science ®Google Scholar
• Hurwitz MD, Kaplan ID, Hansen JL, Prokopios-Davos S, Topulos GP, Wishnow K, Manola J, Bornstein BA, Hynynen K. Hyperthermia combined with radiation in treatment of lovally advanced prostate cancer is associated with a favourable toxicity profile. Int J Hyperthermia 2005; 21: 649–656
   PubMed Web of Science ®Google Scholar
• Algan O, Fosmire H, Hynynen K, Dalkin B, Cui H, Drach G, Stea B, Cassady JR. External beam radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate carcinoma. Cancer 2000; 89: 399–403
   PubMed Web of Science ®Google Scholar
• Kalapurakal JA, Pierce M, Chen A, Sathiaseelan V. Efficacy of irradiation and external hyperthermia in locally advanced, hormone-refractory or radiation recurrent prostate cancer: A preliminary report. Int J Radiat Oncol Biol Phys 2003; 57: 654–664
   PubMed Web of Science ®Google Scholar
• Tilly W, Gellermann J, Graf R, Hildebrandt B, Weißbach L, Budach V, Felix R, Wust P. Regional hyperthermia in conjunction with definitive radiotherapy against recurrent or locally advanced prostate cancer T3 pN0 M0. Strahlenther Onkol 2005; 181: 35–41
   PubMed Web of Science ®Google Scholar
• Maier-Hauff K, Rothe R, Scholz R, Gneveckow U, Wust P, Thiesen B, Feussner A, Von Deimling A, Waldöfner N, Felix R, et al. Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: Results of a feasibility study on patients with glioblastoma multiforme. J Neurooncol 2007; 81(1)53–60, Ref. on line 320
   PubMed Web of Science ®Google Scholar
• Van Vulpen M, De Leeuw AAC, Van Gellekom MPR, Van der Hoeven J, De Graeff A, Van Morselaar JRA, Van der Tweel I, Hofman P, Lagendijk JJ, Battermann JJ. A prospective quality of life study in patients with locally advanced prostate cancer, treated with radiotherapy with or without regional or interstitial hyperthermia. Int J Hyperthermia 2003; 19: 402–413
   PubMed Web of Science ®Google Scholar
• Lein M, Koenig F, Misdraji J, McDougal WS, Jung K, Loening SA, Hasan T, Ortel B. Laser-induced hyperthermia in rat prostate cancer: Role of site of tumor implantation. Urology 2000; 56: 167–172
   PubMed Web of Science ®Google Scholar
• Greenstein A, Koontz WW, Jr,. Does local hyperthermia affect metastasis of a human prostate carcinoma grown in athymic nude mice?. Int J Hyperthermia 2002; 18: 285–91
   PubMed Web of Science ®Google Scholar
• Bataille N, Vallencien G, Chopin D. Antitumoral local effect and metastatic risk of focused extracorporeal pyrotherapy on Dunning R-3327 tumors. Eur Urol 1996; 29: 72–77
   PubMed Web of Science ®Google Scholar
• Sherar MD, Gertner MR, Yue CKK, O'Malley ME, Toi A, Gladman AS, Davidson SR, Trachtenberg J. Interstitial microwave thermal therapy for prostate cancer: Method of treatment and results of a phase I/II trial. J Urol 2001; 166: 1707–1714
   PubMed Web of Science ®Google Scholar
• Shariat SF, Raptidis G, Masatoschi M, Bergamaschi F, Slawin KM. Pilot study of radiofrequency interstitial tumor ablation (RITA) for the treatment of radio-recurrent prostate cancer. Prostate 2005; 65(3)26–267
   Google Scholar
• Gelet A, Chapelon JY, Poissonnier L, Bouvier R, Rouviere O, Curiel L, Janier M, Vallencien G. Local recurrence of prostate cancer after external beam radiotherapy: Early experience of salvage therapy using high-intensity focused ultrasonography. Urology 2004; 63: 625–629
   PubMed Web of Science ®Google Scholar
• Master VA, Shinohara K, Carroll PR. Ferromagnetic thermal ablation of locally recurrent prostate cancer: Prostate specific antigen results and immediate/intermediate morbidities. J Urol 2004; 172: 2197–2202
   PubMed Web of Science ®Google Scholar